Intestinal Disorders News

Diverticulosis is a condition that occurs when diverticula are present in the intestine, without signs of inflammation, and does not cause diverticulitis or diverticular bleeding, according to the NIH.

In a new retrospective analysis, solid organ transplantation saved more than 2 million life-years, including more than 400,000 among liver transplant recipients, during a 25-year period, according to new study data published in JAMA Surgery.

According to results from a US product evaluation comparing ostomy pouching systems conducted last year, clinicians and users preferred a new device that offered a better fit, discretion and overall patient experience, the manufacturer announced this week.

Among immunocompetent adult patients, steroid use and red blood cell transfusion within 1 month of colitis diagnosis were independent risk factors for cytomegalovirus colitis, according to recent study findings.

An observational treatment strategy for uncomplicated acute diverticulitis did not result in short- or long-term repercussions compared with an antibiotic treatment strategy, according to data presented at UEG Week.

The FDA recently approved a blood test used in predicting risk for transplant rejection in patients aged younger than 21 years who undergo liver or small bowel transplantation.

PHILADELPHIA — Compared with warfarin, gastrointestinal bleeding risk associated with the novel oral anticoagulants dabigatran and rivaroxaban increased with age, according to data presented at the ACG Annual Scientific Meeting.

Mesalamine was not effective in the prevention of recurrent diverticulitis compared with placebo, according to results from two phase 3 clinical trials.

Concomitant use of nonsteroidal anti-inflammatory drugs, COX-2 inhibitors or low-dose aspirin with selective serotonin reuptake inhibitors, and other drug combinations, significantly raised the risk for upper gastrointestinal bleeding, according to new research data.

The European Medicines Agency Committee for Orphan Medicinal Products has granted orphan drug designation to Oxabact for the treatment of short bowel syndrome, according to a company press release.